PAX6 and hepatocellular carcinoma: As observed by Shih et al. (2016), increased methylation of Paired-box 6 (PAX6) was more frequently seen in HCV-positive HCC (61.3%) in comparison with HBV-positive HCC (22.1%) in a cohort of 160 patients [11].